The present invention relates to pharmaceutical compositions comprising combinations of amino acids, vitamins, and minerals, which prevent the occurrence of adverse effects associated with prolonged use of glucocorticoids (GCs), especially those of particular relevance due to their high frequency and potential debilitating effect for the patient. These effects are steroid myopathy, hyperglycemia and loss of bone mass.
